IL17A and liver dysplastic nodule: We observed that genetic depletion of IL-17 did not alter the blood glucose profile in diabetic mice, but did attenuate albuminuria, glomerular hypertrophy, interstitial fibrosis and inflammation within the kidney, suggesting a pathogenic role for IL-17A in a multi-low dose STZ-induced model of DN.